With computer-assisted DNA sequencing machines running faster and more cheaply, researchers are now entering Phase II of human genome research. Companies are patenting and privatizing the commercially-important bits of variation found in individuals, indigenous peoples, disease and disability groups, and ethnically-distinct communities.
Phase II for Human Genome Research
Submitted on 01 February 2000
Human Genetic Diversity Enters the Commercial Mainstream